Cancer vaccines.
Pardoll
D M
DM
Johns Hopkins Oncology Center, Baltimore, Maryland 21205-2196, USA.
D000938:Antigen-Presenting Cells / Q000276:immunology; D000943:Antigens, Differentiation / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D019496:Cancer Vaccines; D003713:Dendritic Cells / Q000276:immunology; D016147:Genes, Tumor Suppressor; D006360:Heat-Shock Proteins / Q000502:physiology; D006801:Humans; D007111:Immunity, Cellular; D008545:Melanoma / Q000276:immunology / Q000517:prevention & control / Q000628:therapy; D009369:Neoplasms / Q000276:immunology / Q000517:prevention & control / Q000628:therapy; D009857:Oncogenes; D009858:Oncogenic Viruses / Q000276:immunology; D009928:Organ Specificity; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology; D019444:Vaccines, DNA / Q000276:immunology / Q000627:therapeutic use; D014614:Vaccines, Synthetic / Q000276:immunology / Q000627:therapeutic use
D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D006360:Heat-Shock Proteins; D011518:Proto-Oncogene Proteins; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic